Anergis SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Anergis SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10788
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anergis SA (Anergis) is a clinical stage biopharmaceutical company that discovers, develops and markets immunotherapy products. The company uses synthetic, pharmaceutical-grade contiguous overlapping peptide to derive allergy immunotherapeutics from its proprietary long peptide technology platform. Its products comprise Aller T, Aller R and AllerDM. The company’s Aller R is a COP allergy vaccine for patients with moderate to severe allergy to ragweed pollen. Its AllerDM is a COP allergy vaccine for patients with house dust mite allergy. The company operates in Japan, China, Switzerland and others. Anergis is headquartered in Lausanne, Switzerland.

Anergis SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Anergis SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anergis SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anergis SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anergis SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anergis SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anergis SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Anergis Raises USD5.2 Million in Venture Financing 10
Anergis Raises USD15 Million in Series B Venture Financing 11
Anergis Raises US$9 Million In Venture Financing 12
Partnerships 14
Mymetics and Anergis Enter into Research Partnership 14
Anergis SA – Key Competitors 15
Anergis SA – Key Employees 16
Anergis SA – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Jan 24, 2017: Anergis Appoints Klaus Schollmeier as New Chairman of the Board of Directors 18
Clinical Trials 19
Sep 06, 2017: Anergis Announces Top Line Results From Large-Scale ATIBAR Trial With Ultra-Fast Allergy Immunotherapy AllerT 19
Feb 08, 2017: Anergis Completes Patient Recruitment In Large-Scale ATIBAR Trial With Ultra-Fast Allergy Immunotherapy AllerT 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Anergis SA, Pharmaceuticals & Healthcare, Key Facts 2
Anergis SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anergis SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anergis SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anergis SA, Deals By Therapy Area, 2012 to YTD 2018 8
Anergis SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Anergis Raises USD5.2 Million in Venture Financing 10
Anergis Raises USD15 Million in Series B Venture Financing 11
Anergis Raises US$9 Million In Venture Financing 12
Mymetics and Anergis Enter into Research Partnership 14
Anergis SA, Key Competitors 15
Anergis SA, Key Employees 16

List of Figures
Anergis SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anergis SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anergis SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anergis SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anergis SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anergis SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anergis SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anergis SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Anergis SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Westmoreland Coal Company:企業の戦略・SWOT・財務情報
    Westmoreland Coal Company - Strategy, SWOT and Corporate Finance Report Summary Westmoreland Coal Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Groupe Bruxelles Lambert SA (GBLB):企業の財務・戦略的SWOT分析
    Groupe Bruxelles Lambert SA (GBLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Cybernet Systems Corporation:企業の戦略・SWOT・財務情報
    Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Linamar Corporation (LNR):企業の財務・戦略的SWOT分析
    Linamar Corporation (LNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Monteloeder S.L.:戦略・SWOT・企業財務分析
    Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report Summary Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • OncoSec Medical Inc (ONCS)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company that offers services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through i …
  • Companhia Energetica de Sao Paulo:発電所・企業SWOT分析
    Companhia Energetica de Sao Paulo - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Cosan Ltd:企業の戦略・SWOT・財務情報
    Cosan Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosan Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Hong Kong Aircraft Engineering Co. Ltd:企業の戦略・SWOT・財務情報
    Hong Kong Aircraft Engineering Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Hong Kong Aircraft Engineering Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Keane Group Inc (FRAC):企業の財務・戦略的SWOT分析
    Keane Group Inc (FRAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向
    SREI Infrastructure Finance Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SREI Infrastructure Finance Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • MAXONS Restorations Inc:企業の戦略的SWOT分析
    MAXONS Restorations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • NetSol Technologies, Inc. (NTWK):企業の財務・戦略的SWOT分析
    NetSol Technologies, Inc. (NTWK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CeraPedics Inc:医療機器:M&Aディール及び事業提携情報
    Summary CeraPedics Inc (Cerapedics) is a medical device company that develops and commercializes novel osteobiologic products. The company’s products include i-factor putty, a biologic bone graft that uses a unique small peptide attachment factor to target specific integrins in osteogenic cells to i …
  • Danaher Corporation:企業の戦略・SWOT・財務情報
    Danaher Corporation - Strategy, SWOT and Corporate Finance Report Summary Danaher Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務分析
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Peregrine Holdings Ltd:企業の戦略・SWOT・財務分析
    Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Peregrine Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fortum Corp (FORTUM):石油・ガス:M&Aディール及び事業提携情報
    Summary Fortum Corp (Fortum) is a clean energy company, which generates, distributes and sells heat and electricity. The company undertakes operation and maintenance of power plants; and offers energy-related services. Fortum's operational assets include hydropower plants, condensing power plants, w …
  • CardioGenics Inc:企業の製品パイプライン分析2018
    Summary CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company’s products include QL care analyzer, immunoassay tests, and paramagnetic beads, among ot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆